Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference. The report (http://www.iovs.
Navigation
Daily News
- Sibley Outsources to CareTech
- Vendors: Ease MU Criteria
- Breast Cancer Treated by Freezing Tumors
- Women More Likely to Die After Heart Attack
- PERSEUS Trial Results Demonstrate Positive Safety And Efficacy Outcomes For Boston Scientific’s Novel Platinum Chromium TAXUS® Element Stent
Translator
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||
| By N2H | |||||||||